Ipca Laboratories Limited
NSE:IPCALAB.NS
Overview | Financials
Company Name | Ipca Laboratories Limited |
Symbol | IPCALAB.NS |
Currency | INR |
Price | 1,558.65 |
Market Cap | 395,435,739,600 |
Dividend Yield | 0.16% |
52-week-range | 1,025.55 - 1,708.65 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Pranay Premchand Godha |
Website | https://www.ipca.com |
An error occurred while fetching data.
About Ipca Laboratories Limited
Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD